Showing 99,481 - 99,500 results of 103,558 for search '(( 2 step decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.84s Refine Results
  1. 99481

    Image_3_Characterization and Comparison of Microbiota in the Gastrointestinal Tracts of the Goat (Capra hircus) During Preweaning Development.TIF by Bibo Li (10508)

    Published 2019
    “…As a whole, the microbial richness and diversity showed a clear increasing trend as the kids aged and alpha diversity differed significantly among GIT compartments mainly occurring at middle day ages (14 and 28 days). …”
  2. 99482
  3. 99483
  4. 99484
  5. 99485
  6. 99486
  7. 99487
  8. 99488
  9. 99489
  10. 99490
  11. 99491

    Table_6_Characterization and Comparison of Microbiota in the Gastrointestinal Tracts of the Goat (Capra hircus) During Preweaning Development.docx by Bibo Li (10508)

    Published 2019
    “…As a whole, the microbial richness and diversity showed a clear increasing trend as the kids aged and alpha diversity differed significantly among GIT compartments mainly occurring at middle day ages (14 and 28 days). …”
  12. 99492
  13. 99493
  14. 99494
  15. 99495
  16. 99496
  17. 99497
  18. 99498
  19. 99499

    Table_2_Characterization and Comparison of Microbiota in the Gastrointestinal Tracts of the Goat (Capra hircus) During Preweaning Development.DOCX by Bibo Li (10508)

    Published 2019
    “…As a whole, the microbial richness and diversity showed a clear increasing trend as the kids aged and alpha diversity differed significantly among GIT compartments mainly occurring at middle day ages (14 and 28 days). …”
  20. 99500

    Image_3_Saracatinib synergizes with enzalutamide to downregulate AR activity in CRPC.jpg by Ralph E. White (8599362)

    Published 2023
    “…We observed robust synergy between the SRC kinase inhibitor, saracatinib, and enzalutamide, in the AR-FL+/AR-V+ CRPC cell lines, LNCaP95 and 22Rv1. We also observed that saracatinib significantly decreases AR Y<sup>534</sup> phosphorylation, a key SRC kinase substrate residue, on AR-FL and AR-Vs, along with the AR regulome, supporting key mechanisms of synergy with enzalutamide. …”